Ipsen Sa S/Adr (IPSEY) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Ipsen Sa.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.132 -- 00:00:05.837 Hello, everyone. I'm delighted to welcome you this afternoon to our H1 2025 00:00:05.837 -- 00:00:09.881 results presentation, which can also be found on Ibsen.com. 00:00:09.881 -- 00:00:14.406 I want to use the time we have together to focus on the progress Ibsen delivered in the 00:00:14.406 -- 00:00:19.491 first half of 2025 and all the future opportunities and platforms for growth. 00:00:19.491 -- 00:00:24.836 Please turn to slide two. Please take note of our forward-looking statements, which outline 00:00:24.836 -- 00:00:28.960 the routine risks and uncertainties contained within this presentation. 00:00:28.960 -- 00:00:33.545 Also, All my comments on growth will be based on constant exchange rates. 00:00:33.545 -- 00:00:38.311 Please turn to slide three. I'm going to take you through the presentation of our latest 00:00:38.311 -- 00:00:42.757 business update, followed by Christelle Hügge, head of research and development, who 00:00:42.757 -- 00:00:47.903 will provide an R&D update, while our CFO, Aymeric Le Chatelier, will take you 00:00:47.903 -- 00:00:53.651 through the financials. At the end of the presentation, all three of us will be participating 00:00:53.651 -- 00:00:58.076 in the question and answer session. Let's begin by looking at today's highlight. 00:00:58.076 -- 00:01:00.680 Please turn to slide four. 00:01:00.680 -- 00:01:05.745 Turn to slide five. Today's headlines illustrate how we are continuing to 00:01:05.745 -- 00:01:10.851 produce sustainable growth. Total sales grew by 11.4% in the 00:01:10.851 -- 00:01:15.796 first half of 2025, accompanied by a core operating margin of 36%. 00:01:15.796 -- 00:01:21.002 As you have seen, we announced last week the European Commission approval 00:01:21.002 -- 00:01:27.0...